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Background: Ondansetron is used to reduce tramadol induced postoperative nausea and vomiting (PONV). Studies on 
patient-controlled analgesia (PCA) found that ondansetron reduces the analgesic efficacy of tramadol. Drug requirement in PCA 
and in conventional intravenous analgesia without PCA device may differ. This study evaluated the effect of ondansetron on 
analgesic efficacy of tramadol for postoperative analgesia without a PCA device.
Methods: A prospective, randomised, placebo-controlled, double-blind parallel group study was conducted on 126 euthyroid 
patients of ASA I and II, aged between 30 and 65 years undergoing hemithyroidectomy under general anaesthesia. Patients were 
divided into group O and group C. At the time of closure of strap muscles, patients in group O received tramadol 1.5 mg/kg IV 
and ondansetron 0.1 mg/kg (diluted to 4 ml) IV and those in group C received tramadol 1.5 mg/kg IV and normal saline 4 ml IV. 
Duration of analgesia, pain score (VAS), PONV and sedation scores were analysed.
Results: Duration of analgesia was longer in group C compared with group O (164.1 min vs. 76.3 min, p < 0.05). Postoperative VAS 
score was higher in group O (p < 0.001). Group C showed higher PONV and sedation score.
Conclusion: Ondansetron reduces the duration and quality of analgesia of tramadol administered conventionally without a PCA 
device.
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Introduction
Adequate postoperative pain management is of utmost 
importance in anaesthesia practice. Good postoperative 
analgesia results in quicker resumption of normal pulmonary 
function, early ambulation, shortened hospital stay and reduced 
hospital cost. Tramadol, a moderately potent partial opioid 
agonist, is commonly used for intraoperative as well as 
postoperative analgesia. However, its use has been associated 
with a higher incidence of postoperative nausea and vomiting 
(PONV).1 For this reason, the antiemetic ondansetron is often co-
administered. Some studies2–5 on patient-controlled analgesia 
(PCA) have found that the analgesic efficacy of tramadol was 
reduced by concurrent administration of ondansetron. 
Conversely, few studies6,7 showed no reduction of analgesic 
efficacy of tramadol when ondansetron was co-administered. 
Drug requirement in PCA and in conventional intravenous opioid 
analgesia without using a PCA device may differ,8 but studies 
evaluating the effect of ondansetron on conventionally delivered 
tramadol are lacking. Hence, we conducted this study to evaluate 
the effect of intravenous ondansetron on the analgesic efficacy 
of intravenous tramadol administered conventionally without a 
PCA device for postoperative analgesia.
Methodology
This prospective, randomised, placebo-controlled, double-blind 
parallel group study was conducted at IPGME&R, Kolkata after 
receiving approval from the Institutional Ethical Committee. 
Euthyroid patients belonging to ASA physical status I and II, aged 
between 30 and 65  years and undergoing hemithyroidectomy 
under general anaesthesia, were included in the study. Patients 
with severe cardiovascular, pulmonary, hepatic, renal and 
neurological diseases (ASA Grade III and IV), with anticipated 
difficult airway, with hypothyroidism or hyperthyroidism, with 
known hypersensitivity to study drugs, with a history of alcohol 
or drug abuse, morbidly obese, pregnant and lactating patients 
and those receiving monoamine oxidase inhibitors, study drugs 
or any other antiemetic medication within 24 hours were 
excluded from the study.
Sample-size calculation was done using the PS Power and 
Sample Size Calculations (Version 2.1.30, February 2003; 
Department of Biostastics, Vanderbilt University, Nashville, TN, 
USA). The time duration between the intraoperative injection of 
tramadol and the requirement for rescue analgesia in the 
postoperative period was taken as the primary study parameter. 
A pilot study was done on 10 patients undergoing surgery under 
general anaesthesia to obtain the mean and standard deviation 
values for the time of requirement of rescue analgesic in the 
postoperative period. It was calculated that to accept or reject 
the null hypothesis with a power of 80% and a 5% probability of 
type I error, 63 patients were required per group in order to 
detect a time difference of 30 minutes between the groups, this 
calculation assume a standard deviation of 45 minutes for the 
primary outcome measure.
Complete pre-anaesthetic evaluation was performed in each 
patient including detailed history-taking, thorough physical 
examination including airway examination and routine 
preoperative investigations including complete haemogram, 
serum urea, creatinine, fasting & post-prandial blood sugar, 
thyroid profile, chest X-ray PA view and electrocardiogram (ECG).
Written informed consent was taken from each patient. All 
patients received oral alprazolam 0.5  mg the night before 
surgery. Peripheral intravenous access was secured with an 18-G 
IV cannula in a forearm vein. Standard intraoperative monitoring 
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was applied including pulse rate, non-invasive blood pressure, 
oxygen saturation (SpO2) capnography and ECG. All patients 
received glycopyrrolate 0.2 mg IV 30 minutes preoperatively and 
fentanyl 2mcg/kg IV 5 minutes before induction of anaesthesia. 
After proper pre-oxygenation, anaesthesia was induced with 
thiopentone sodium 5 mg/kg IV. Tracheal intubation was done 
with a PVC cuffed endotracheal tube of appropriate size after 
achieving adequate relaxation with vecuronium 0.1  mg/kg IV. 
Anaesthesia was maintained with 66% nitrous oxide, 33% 
oxygen, isoflurane 0.9–1% and vecuronium 0.02  mg/kg IV. All 
patients received diclofenac 75  mg IV infusion at the time of 
surgical incision. Boluses of fentanyl IV were given to the patients 
requiring further intraoperative analgesia and these patients 
were dropped from the study.
The study population was randomly divided into two groups, 
group O and group C, with the help of a computer-generated 
random-number list. At the time of closure of the strap muscles, 
patients in group O (n = 63) received tramadol 1.5 mg/kg IV and 
ondansetron 0.1 mg/kg (diluted to 4 ml) IV and those in group C 
(n = 63) received tramadol 1.5 mg/kg IV and normal saline 4 ml IV. 
Residual neuromuscular blockade was reversed with neostigmine 
0.05 mg/kg IV and glycopyrrolate 0.01 mg/kg IV. Patients were 
extubated after fulfilling the criteria for adequate reversal.
Pain was evaluated using a visual analogue scale (VAS) where 0 
represents no pain and 10 represents the worst imaginable pain. 
PONV9 and degree of sedation3 were assessed postoperatively by 
a four-point ordinal scale (Table 1).
Rescue analgesic was given in the form of paracetamol 1  g IV 
when VAS score was >3. This was the primary end point of the 
study. The time duration between administration of 
intraoperative tramadol and rescue analgesic was noted and 
compared between two groups. VAS score, PONV score, degree 
of sedation, heart rate, blood pressure, respiratory rate and 
oxygen saturation were evaluated at an interval of 30 minutes 
until the patient received rescue analgesia.
Patients with a PONV score of 3 were treated with metoclopramide 
10  mg IV as a rescue antiemetic and were dropped from the 
study. Any adverse event in the first 24 hours postoperatively 
was also recorded.
The time duration between the intraoperative injection of 
tramadol and the requirement for rescue analgesia in the 
postoperative period was considered as the primaryoutcome. 
The VAS score in the postoperative period in the two groups was 
taken as the secondary outcome.
Statistical analysis was done using the software Statistica version 
6 (StatSoft Inc., Tulsa, OK, USA, 2001). Comparison of parametric 
data was done by Student’s unpaired t-test. Nonparametric data 
were compared between two groups with the Mann–Whitney U 
test. Degree of sedation was compared with a chi-square test. A 
p-value of <0.05 was considered statistically significant.
Results
Three patients in group O and two patients in group C required 
additional fentanyl for intraoperative analgesia. Two patients in 
group C required metoclopramide as rescue antiemetic in the 
postoperative period. One patient in group O needed urgent 
re-exploration of the wound postoperatively due to a haematoma. 
All these patients were excluded from the study. Finally, 126 
patients (63 patients in each group) were included for statistical 
analysis.
The groups were comparable in terms of demographic profile, 
duration of surgery and dose of tramadol administered 
intraoperatively (Table 2).
Duration of analgesia was longer in the control group in 
comparison with the study group. Figure 1 shows a statistically 
significant time difference between intraoperative tramadol 
administration and postoperative rescue analgesia requirement 
in group C compared with group O (p-value < 0.05), with group C 
reporting longer analgesia.
Table 3 shows statistically significant higher VAS score in the 
immediate postoperative period and after 30 and 60 minutes in 
group O compared with group C (Table 3).
In comparison with group O, group C showed (Table 4) a higher 
PONV score in the immediate postoperative period and after 30 
and 60 minutes.
The sedation score in the immediate postoperative period was 
higher in group C compared with group O (Table 5).
Table 1: Scoring criteria for PONV and sedation
Condition Scoring criteria
PONV 0 = No nausea or vomiting
1 = Nausea, no vomiting
2 = Vomiting
3 = Persistent vomiting
Sedation 0 = Patient fully awake
1 = Patient slightly drowsy
2 = Patient sleeping but easily arousable
3 = Patient unconscious, not arousable
Table 2: Demographic profile and operative details
Factor Group O (n = 63) Group C (n = 63) p-value
(Mean ± SD) (Mean ± SD)
Age (years) 41.3 ± 8.90 42.4 ± 9.78 >0.05
Sex (M:F) 19:44 13:50 >0.05
Bodyweight (kg) 56.4 ±. 6.87 58.3 ± 5.13 >0.05
ASA class (I/II) 50/13 52/11 >0.05
Duration of surgery (minutes) 129.92 ± 19.25 131.75 ± 20.06 >0.05
Dose of tramadol given intraoperatively (mg) 84.6 ± 10.30 87.4 ± 7.70 >0.05
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In the postoperative period, heart rate, blood pressure, 
respiratory rate and oxygen saturation remained within the 
clinical range (Table 6). Postoperative heart rate was significantly 
higher in group O compared with group C. No difference was 
found between the two groups in respect of other postoperative 
monitoring parameters.
Discussion
Tramadol is a synthetic 4-phenyl-piperidine analogue of 
codeine.10 It is a centrally acting analgesic which shows moderate 
affinity for μ receptors and weak affinity for κ and δ opioid 
receptors.11 It also exerts analgesic effect by inhibiting serotonin 
and norepinephrine reuptake thereby blocking the nociceptive 
impulses at the spinal level.10 In the liver, tramadol undergoes 
O-demethylation, mediated by an isoenzyme CYP2D6 to form an 
active metabolite, O-demethyl tramadol (M1derivative). This 
metabolite exhibits higher affinity for μ receptors than the parent 
drug.10 Tramadol is frequently used for intraoperative as well as 
postoperative analgesia. However, its use is associated with a 
higher incidence of PONV.12 Ondansetron is a highly selective 
5HT3 receptor antagonist that is an effective agent in reducing 
PONV.1 It reduces PONV by blocking 5-HT3 receptors centrally at 
the area postrema and peripherally at vagus nerve terminals.13
Figure 1: Time duration (minutes) between intraoperative tramadol 
administration and postoperative rescue analgesic requirement.
Table 3: Postoperative VAS score
Postoperative VAS Group O (n = 63) Group C (n = 63) p-value
(Mean ± SD) (Mean ± SD)
At 0 minutes 0.86 ± 0.82 0.35 ± 0.54 <0.001
At 30 minutes 1.44 ± 0.99 0.43 ± 0.56 <0.001
At 60 minutes 2.51 ± 0.66 1.16 ± 0.68 <0.001
Table 4: Postoperative PONV score
Factor Group O (n = 63) Group C (n = 63) p-value
(Mean ± SD) (Mean ± SD)
Postoperative PONV score at 0 minutes 0.06 ± 0.24 0.73 ± 0.74 < 0.001
Postoperative PONV score at 30 minutes 0.03 ± 0.18 0.44 ± 0.53 < 0.001
Postoperative PONV score at 60 minutes 0.09 ± 0.35 0.25 ± 0.47 < 0.05
Table 5: Postoperative sedation score
Note: p-value < 0.001 at 0 minutes.
Degree of sedation in postoperative period Group O (n = 63) Group C (n = 63)
At 0 min At 30 min At 60 min At 0 min At 30 min At 60 min
0 41 55 57 5 53 56
1 14 7 6 32 10 7
2 8 1 0 26 0 0
3 0 0 0 0 0 0
Table 6: Postoperative monitoring parameters
Factor Group O (n = 63) Group C (n = 63) p-value
(Mean ± SD) (Mean ± SD)
Heart rate (per minute) 83.9 ± 7.23 79.7 ± 7.03 < 0.05
SBP (mm Hg) 126.8 ± 8.29 127.6 ± 6.67 > 0.05
DBP (mm Hg) 80.8 ± 6.92 81.7 ± 6.83 > 0.05
SpO2 (%) 98.5 ± 0.72 98.5 ± 0.80 > 0.05
Respiratory rate (per minute) 12.6 ± 0.91 12.4 ± 0.82 > 0.05
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In summary, administration of ondansetron with tramadol is 
better avoided due to the potential for reduction in the analgesic 
effect of tramadol. Consideration should be given to using an 
alternative antiemetic like metoclopramide in the presence of 
tramadol to reduce the incidence of PONV.26 Randomised 
controlled studies evaluating the effect of granisetron, 
tropisetron and palanosetron on the analgesic efficacy of 
tramadol are lacking. Further studies may be conducted in this 
field. In future, similar studies may be conducted using different 
doses of tramadol and ondansetron.
Conclusion
Administration of ondansetron with tramadol is better avoided 
as it reduces the duration and quality of analgesia with tramadol 
administered conventionally without using a PCA device.
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